These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21806738)

  • 21. Seasonal trivalent influenza vaccine for 2010-2011.
    Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism for Seasonal Vaccine Effect on Pandemic H1N1 Risk Remains Uncertain.
    Skowronski DM; Janjua NZ; Hottes TS; De Serres G
    Clin Infect Dis; 2011 Mar; 52(6):831-2; author reply 832-3. PubMed ID: 21367740
    [No Abstract]   [Full Text] [Related]  

  • 23. Preparing for H1N1 influenza: New Jersey preparedness efforts ongoing for nearly a decade.
    Howard H
    MD Advis; 2009; 2(4):23-6. PubMed ID: 21250538
    [No Abstract]   [Full Text] [Related]  

  • 24. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.
    Tuppin P; Samson S; Weill A; Ricordeau P; Allemand H
    Vaccine; 2011 Jun; 29(28):4632-7. PubMed ID: 21550376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.
    Dikow R; Eckerle I; Ksoll-Rudek D; Hampel H; Schwenger V; Zeier M; Schnitzler P; Sommerer C
    Am J Kidney Dis; 2011 May; 57(5):716-23. PubMed ID: 21349617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys.
    Walter D; Böhmer MM; Heiden Ma; Reiter S; Krause G; Wichmann O
    Vaccine; 2011 May; 29(23):4008-12. PubMed ID: 21463683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec.
    Fabry P; Gagneur A; Pasquier JC
    Vaccine; 2011 Feb; 29(9):1824-9. PubMed ID: 21219988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.
    Tan L; Lu H; Zhang D; Wang K; Tian M; Liu C; Liu Y; Hu B; Jin N
    Sci China Life Sci; 2011 Apr; 54(4):293-9. PubMed ID: 21416231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pandemic vaccines].
    Floret D
    Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
    [No Abstract]   [Full Text] [Related]  

  • 33. Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen.
    Chauvat A; Benhamouda N; Loison E; Gougeon ML; Gey A; Levionnois E; Ravel P; Abitbol V; Roncelin S; Marcheteau E; Quintin-Colonna F; Fridman WH; Launay O; Tartour E
    J Immunol Methods; 2012 Apr; 378(1-2):81-7. PubMed ID: 22366633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of Ontario's pandemic vaccine program.
    Rolland-Harris E; Tepper M
    Vaccine; 2011 May; 29(22):3829; author reply 3830-1. PubMed ID: 20831912
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention: Vaccine for all seasons.
    Schlütter J
    Nature; 2011 Nov; 480(7376):S6-8. PubMed ID: 22158298
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse effects following pandemic influenza (H1N1) 2009 vaccination.
    Bolam B; Grills N
    Aust N Z J Public Health; 2009 Dec; 33(6):584. PubMed ID: 20078579
    [No Abstract]   [Full Text] [Related]  

  • 37. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A (H1N1) 2009 pandemic virus: learning from the first wave, preparing for the second.
    Lee CK
    Med J Malaysia; 2010 Mar; 65(1):1-2. PubMed ID: 21265237
    [No Abstract]   [Full Text] [Related]  

  • 39. Why were Turks unwilling to accept the A/H1N1 influenza-pandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic.
    Gaygısız Ü; Gaygısız E; Özkan T; Lajunen T
    Vaccine; 2010 Dec; 29(2):329-33. PubMed ID: 20979988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
    Choo AY; Broderick KE; Kim JJ; Sardesai NY
    IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.